Advertisement

ADVERTISEMENT

Jessica Garlewicz, Associate Digital Editor

psoriatic rash
FDA Alerts
Deucravacitinib Approved for Adults With Moderate to Severe Plaque Psoriasis
09/12/2022
Last week, the US Food and Drug Administration announced approval of deucravacitinib as an oral treatment for adults with moderate to severe plaque psoriasis.
Last week, the US Food and Drug Administration announced approval of deucravacitinib as an oral treatment for adults with moderate to severe plaque psoriasis.
Last week, the US Food and Drug...
09/12/2022
The Dermatologist
NRS Approved Features
Key Insights Into Rhinophyma in Rosacea
08/16/2022
Up to 10% of the world’s population is affected by rosacea. Rhinophyma can be seen in patients with chronic rosacea, particularly men aged 50 years and older.
Up to 10% of the world’s population is affected by rosacea. Rhinophyma can be seen in patients with chronic rosacea, particularly men aged 50 years and older.
Up to 10% of the world’s...
08/16/2022
The Dermatologist
News
Cutaneous T-Cell Lymphoma and Psoriasis Associated With Memory Impairment
08/09/2022
Researchers aimed to determine if CTCL and PsO had an impact on cognitive functioning due to psychological and health-related quality of life (HR-QOL) status.
Researchers aimed to determine if CTCL and PsO had an impact on cognitive functioning due to psychological and health-related quality of life (HR-QOL) status.
Researchers aimed to determine...
08/09/2022
The Dermatologist
News
Patients With Psoriasis or Psoriatic Arthritis May Develop Diffuse Parenchymal Lung Disease
08/05/2022
Researchers searched for patients with PsO or PsA in addition to diffuse parenchymal lung disease via pathology consultation files.
Researchers searched for patients with PsO or PsA in addition to diffuse parenchymal lung disease via pathology consultation files.
Researchers searched for...
08/05/2022
Dermatology
pediatric patient hand
FDA Alerts
Ustekinumab Approved For Pediatric Patients With Active Psoriatic Arthritis
08/01/2022
Today, the US Food and Drug Administration announced approval of ustekinumab for the treatment of pediatric patients aged 6 years and older with active psoriatic arthritis.
Today, the US Food and Drug Administration announced approval of ustekinumab for the treatment of pediatric patients aged 6 years and older with active psoriatic arthritis.
Today, the US Food and Drug...
08/01/2022
The Dermatologist
News
Stress Signaling and STAT1 Activation Play Key Role in Disease Progression of Hidradenitis Suppurativa
07/29/2022
Researchers aimed to analyze the role of keratinocytes in HS lesion formation by comparing the transcriptomes of lesional and perilesional epidermis isolated from patients with HS.
Researchers aimed to analyze the role of keratinocytes in HS lesion formation by comparing the transcriptomes of lesional and perilesional epidermis isolated from patients with HS.
Researchers aimed to analyze the...
07/29/2022
The Dermatologist
News
Hidradenitis Suppurativa Is a Risk Factor for Infection Following Procedures
07/21/2022
Researchers identified adult patients undergoing THA or TKA for degenerative etiologies from PearlDiver datasets to match with patients without HS based on age, sex, and Elixhauser Comorbidity Index.
Researchers identified adult patients undergoing THA or TKA for degenerative etiologies from PearlDiver datasets to match with patients without HS based on age, sex, and Elixhauser Comorbidity Index.
Researchers identified adult...
07/21/2022
The Dermatologist
Dr Mercedes Gonzalez
Q&As
Dupilumab Add-on Maintenance Treatment For Children With Atopic Dermatitis
07/21/2022
The Dermatologist met with Mercedes Gonzalez, MD, an investigator in the randomized, placebo-controlled pivotal trial, to discuss dupilumab's recent approval.
The Dermatologist met with Mercedes Gonzalez, MD, an investigator in the randomized, placebo-controlled pivotal trial, to discuss dupilumab's recent approval.
The Dermatologist met with...
07/21/2022
The Dermatologist
Robert Kalb, MD
Q&As
Treatment Targets in Psoriasis: Alleviating the Burden
06/17/2022
Dr Kalb met with The Dermatologist to define the treatment targets for psoriasis and how often dermatologists should evaluate a patient’s progression toward a treatment target.
Dr Kalb met with The Dermatologist to define the treatment targets for psoriasis and how often dermatologists should evaluate a patient’s progression toward a treatment target.
Dr Kalb met with The...
06/17/2022
The Dermatologist
FDA Alerts
Baricitinib Approved for Adult Patients With Severe Alopecia Areata
06/15/2022
The US Food and Drug Administration recently announced approval of baricitinib oral tablets to treat adult patients with severe alopecia areata.
The US Food and Drug Administration recently announced approval of baricitinib oral tablets to treat adult patients with severe alopecia areata.
The US Food and Drug...
06/15/2022
The Dermatologist

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

Dermatology Week
November 13 ⁠–⁠ November 16
Derm Week
November 13 ⁠–⁠ November 16
November 23 ⁠–⁠ November 24
December 4 ⁠–⁠ December 5
Great Debates & Updates in Diabetic Foot
December 6 ⁠–⁠ December 7
AIBD logo
December 9 ⁠–⁠ December 11
December 9 ⁠–⁠ December 11
Psych Congress Primary Care Online Series
December 12 ⁠–⁠ December 13
December 14 ⁠–⁠ December 15
February 2 ⁠–⁠ February 5
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use